GOG-0263

Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)

Principal Investigator

Sang-Young Ryu

Status

Disease Site

Gynecologic [GY] Cervix

Phase

III

Developmental Therapeutics

No

Primary Objective

To determine if post-operative adjuvant chemo-radiation therapy (CRT) can significantly improve recurrence-free survival (RFS) when compared to radiation therapy (RT) alone in Stage I-IIA cervical cancer patients with intermediate risk factors after treatment with radical hysterectomy.

Patient Population

Post-operative adjuvant chemo-radiation therapy (CRT) or radiation therapy (RT) alone in Stage I-IIA cervical cancer patients with intermediate risk factors after treatment with radical hysterectomy.

Target Accrual

360